May 15, 2026
Women’s Health Week: Investing in the Future of Women’s Care
This Women’s Health Week, we celebrate the founders, healthcare professionals, researchers, and investors pushing the industry forward — and the women whose voices, experiences, and needs are finally driving the future of healthcare innovation.
Key Takeaways
Six scaling companies. Two unicorns. Breakthroughs in fertility, maternal health, menopause, bone health, and at-home diagnostics. One $600B market by 2030 — and a generation of women whose health finally gets the attention it has always deserved.
Women’s Health is Finally Getting the Attention It Deserves
Every May, National Women’s Health Week serves as a reminder that women’s health is not a niche issue, it is a global healthcare, economic, and innovation opportunity. From fertility and maternal health to menopause, pelvic health, and bone density, innovators are finally building solutions for areas that have historically been overlooked or underfunded. At the same time, investors, founders, healthcare leaders, and policy makers are increasingly recognizing that improving outcomes for women represents one of the largest untapped opportunities in healthcare.
That momentum was on full display this month at the Women’s Health Week USA conference in New York, where leaders across the ecosystem gathered to discuss the future of women’s health innovation, investment, and access to care. Hosted at the New York Academy of Medicine, the conference brought together founders, clinicians, investors, and healthcare operators focused on scaling solutions that improve women’s lives.
Portfolia’s Commitment to Women’s Health Innovation
At Portfolia, we’ve long believed that investing in women’s heatlh is both mission-driver and market-smart. In fact, Portfolia’s 2K+ limited partners have made 100+ investments across 50+ women’s health companies— more than any venture firm in the world.
Six Women’s Health Companies Scaling Right Now
To celebrate Women’s Health Week, we've pulled together a free investor brief on six of our companies scaling right now.
The companies featured reflect the breadth of innovation happening across women’s healthcare today. This is just a brief introduction to the companies, to learn more please refer to the investor brief!
Maven is transforming access to virtual care for women and families, supporting patients across fertility, pregnancy, parenting, menopause, and beyond. As one of the leading digital health platforms in women’s care, Maven has helped expand access to specialized support for millions navigating some of life’s most important health journeys.
Mirvie is advancing maternal health through molecular science and predictive diagnostics designed to identify pregnancy complications earlier. Its work has the potential to significantly improve outcomes for both mothers and babies by enabling earlier intervention and more personalized care.
Everly Health helped pioneer accessible at-home testing and digital health management, empowering consumers to take a more proactive role in understanding and managing their health from home. The company continues to reshape how patients engage with preventative care and diagnostics.
Willow reimagined breast pumping with wearable technology that gives mothers greater flexibility, mobility, and autonomy during postpartum life. By combining healthcare innovation with thoughtful product design, Willow has transformed an experience that had long seen little innovation.
Joylux is bringing visibility and innovation to intimate health and pelvic wellness — areas of women’s health that have historically been underserved despite affecting millions of women. Its solutions are helping normalize conversations around women’s wellness and quality of life.
Osteoboost is tackling bone density and osteoporosis prevention, a critical but often overlooked area of women’s health. As longevity and healthy aging become increasingly important priorities, innovations supporting bone health have the potential to improve mobility, independence, and long-term well-being for millions of women.
A Growing Market — and a Growing Movement
Together, these companies represent a larger shift happening across healthcare: women’s health is finally being recognized as a category worthy of serious innovation, research, and investment.
For decades, many women’s health conditions were underdiagnosed, understudied, or dismissed entirely. Venture funding in the sector lagged despite women making the majority of healthcare decisions for their families. Today, however, founders and investors alike are proving that addressing women’s needs creates not only meaningful impact, but also scalable businesses capable of transforming healthcare systems globally.
The opportunity ahead remains enormous. Whether it’s expanding maternal care access, improving menopause support, advancing fertility science, or building technologies that empower women to manage their health more proactively, innovation in women’s health has the power to improve outcomes for generations to come.
Looking Ahead
This Women’s Health Week, we celebrate the founders, healthcare professionals, researchers, and investors pushing the industry forward — and the women whose voices, experiences, and needs are finally driving the future of healthcare innovation.